Clinical Trial Update: Evaluation of GLR2007 for Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating GLR2007 for advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Non-small Cell Lung Cancer

Drugs mentioned

• GLR2007

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Non-small Cell Lung Cancer, Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED